A.-S. Baumann

468 total citations
19 papers, 354 citations indexed

About

A.-S. Baumann is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Radiation. According to data from OpenAlex, A.-S. Baumann has authored 19 papers receiving a total of 354 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 7 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Radiation. Recurrent topics in A.-S. Baumann's work include Radiation Therapy and Dosimetry (8 papers), Advanced Radiotherapy Techniques (6 papers) and Radiopharmaceutical Chemistry and Applications (5 papers). A.-S. Baumann is often cited by papers focused on Radiation Therapy and Dosimetry (8 papers), Advanced Radiotherapy Techniques (6 papers) and Radiopharmaceutical Chemistry and Applications (5 papers). A.-S. Baumann collaborates with scholars based in France, Italy and India. A.-S. Baumann's co-authors include D. Peiffert, Julia Salleron, G. Oldrini, Hélène Barraud, Jean–Pierre Bronowicki, V. Vendrely, V. Marchesi, T. Lacornerie, Marie‐Cécile Le Deley and Stéphane Cattan and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and Annals of Oncology.

In The Last Decade

A.-S. Baumann

19 papers receiving 353 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A.-S. Baumann France 8 176 172 131 115 63 19 354
Jens Ricke Germany 11 289 1.6× 168 1.0× 143 1.1× 91 0.8× 177 2.8× 23 422
Karen Marshall United States 9 323 1.8× 151 0.9× 85 0.6× 120 1.0× 184 2.9× 11 443
Christian Rosner Germany 9 194 1.1× 170 1.0× 115 0.9× 93 0.8× 124 2.0× 11 379
Bin Qiu China 14 111 0.6× 113 0.7× 50 0.4× 153 1.3× 51 0.8× 40 398
Simone Gusmini Italy 10 100 0.6× 181 1.1× 22 0.2× 216 1.9× 58 0.9× 25 399
É. Boucher France 7 397 2.3× 139 0.8× 77 0.6× 140 1.2× 136 2.2× 13 563
Ali Al Asadi Iran 11 379 2.2× 139 0.8× 56 0.4× 121 1.1× 95 1.5× 28 471
Samuel Le Sourd France 15 316 1.8× 296 1.7× 48 0.4× 300 2.6× 109 1.7× 42 634
Carla Rash United States 7 37 0.2× 317 1.8× 179 1.4× 228 2.0× 74 1.2× 9 485
Giulia Riva Italy 10 41 0.2× 106 0.6× 77 0.6× 97 0.8× 84 1.3× 36 316

Countries citing papers authored by A.-S. Baumann

Since Specialization
Citations

This map shows the geographic impact of A.-S. Baumann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.-S. Baumann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.-S. Baumann more than expected).

Fields of papers citing papers by A.-S. Baumann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A.-S. Baumann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.-S. Baumann. The network helps show where A.-S. Baumann may publish in the future.

Co-authorship network of co-authors of A.-S. Baumann

This figure shows the co-authorship network connecting the top 25 collaborators of A.-S. Baumann. A scholar is included among the top collaborators of A.-S. Baumann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A.-S. Baumann. A.-S. Baumann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Baumann, A.-S., Ahmet Ayav, Valérie Laurent, et al.. (2020). Curative Irradiation Treatment of Hepatocellular Carcinoma: A Multicenter Phase 2 Trial. International Journal of Radiation Oncology*Biology*Physics. 107(1). 116–125. 74 indexed citations
2.
Pracht, Marc, É. Chajon, Y. Rolland, et al.. (2019). Phase I/II trial of NBTXR3 activated by SBRT in patients with hepatocellular carcinoma or liver metastasis. Annals of Oncology. 30. v291–v291. 6 indexed citations
3.
Chajon, É., Marc Pracht, Yan Rolland, et al.. (2019). First-in-class hafnium oxide nanoparticles NBTXR3 in the treatment of liver cancers.. Journal of Clinical Oncology. 37(15_suppl). e15642–e15642. 2 indexed citations
4.
Pracht, Marc, Y. Rolland, Thierry de Baère, et al.. (2019). Hafnium Oxide Nanoparticles Activated by SBRT for the Treatment of Hepatocellular Carcinoma and Liver Metastasis: A Phase I/II Trial. International Journal of Radiation Oncology*Biology*Physics. 105(1). S110–S111. 2 indexed citations
5.
Chajon, É., Marc Pracht, Thierry de Baère, et al.. (2019). Hepatocellular carcinoma and liver metastasis treated by hafnium oxide nanoparticles activated by SBRT: A phase I/II trial.. Journal of Clinical Oncology. 37(4_suppl). 340–340. 2 indexed citations
6.
Zaanan, Aziz, Olivier Bouché, Léonor Benhaïm, et al.. (2018). Gastric cancer: French intergroup clinical practice guidelines for diagnosis, treatments and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO). Digestive and Liver Disease. 50(8). 768–779. 66 indexed citations
7.
Peiffert, D., et al.. (2018). Cancer du canal anal : à l’ère de la radiothérapie conformationnelle avec modulation d’intensité, questions en suspens. Cancer/Radiothérapie. 22(6-7). 509–514. 1 indexed citations
8.
Baumann, A.-S., Pascal Eschwège, Jean‐Luc Moreau, et al.. (2018). Prostate-specific antigen bounce in patients treated before 60 years old by iodine 125 brachytherapy for prostate cancer is frequent and not a prognostic factor. Brachytherapy. 17(6). 888–894. 4 indexed citations
9.
Chajon, É., Marc Pracht, Thierry de Baère, et al.. (2018). A phase I/II trial of NBTXR3 nanoparticles activated by SBRT in the treatment of liver cancers.. Journal of Clinical Oncology. 36(4_suppl). TPS551–TPS551. 2 indexed citations
10.
Chajon, É., Marc Pracht, Thierry de Baère, et al.. (2018). NBTXR3, hafnium oxide nanoparticles in the treatment of liver cancer: A phase I/II trial.. Journal of Clinical Oncology. 36(15_suppl). e16194–e16194. 1 indexed citations
11.
Chajon, É., Marc Pracht, Thierry de Baère, et al.. (2018). A phase I/II trial of hafnium oxide nanoparticles activated by radiotherapy in hepatocellular carcinoma and liver metastasis. Annals of Oncology. 29. v92–v92. 2 indexed citations
12.
Pracht, Marc, É. Chajon, Thierry de Baère, et al.. (2018). Hepatocellular carcinoma and liver metastasis treated by hafnium oxide nanoparticles activated by stereotactic body radiation therapy. Annals of Oncology. 29. viii240–viii240. 5 indexed citations
13.
14.
Salleron, Julia, V. Beckendorf, D. Peiffert, et al.. (2017). Intensity-modulated radiation therapy from 70Gy to 80Gy in prostate cancer: six- year outcomes and predictors of late toxicity. Radiation Oncology. 12(1). 99–99. 26 indexed citations
15.
Peiffert, D., et al.. (2016). Radiothérapie des cancers du canal anal. Cancer/Radiothérapie. 20. S183–S188. 10 indexed citations
16.
Peiffert, D., et al.. (2016). Radiothérapie des cancers du rectum. Cancer/Radiothérapie. 20. S179–S182. 8 indexed citations
17.
Baumann, A.-S., Julia Salleron, G. Oldrini, et al.. (2015). Stereotactic body radiation therapy as an ablative treatment for inoperable hepatocellular carcinoma. Radiotherapy and Oncology. 115(2). 211–216. 108 indexed citations
18.
Peiffert, D., A.-S. Baumann, & V. Marchesi. (2014). Treatment of hepatic metastases of colorectal cancer by robotic stereotactic radiation (Cyberknife®). Journal of Visceral Surgery. 151. S45–S49. 10 indexed citations
19.
Oldrini, G., A.-S. Baumann, V. Marchesi, et al.. (2014). Implantation of fiducial markers in the liver for stereotactic body radiation therapy: Feasibility and results. Diagnostic and Interventional Imaging. 96(6). 589–592. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jens Ricke Breakdown of academic impact, for papers by Karen Marshall Breakdown of academic impact, for papers by Christian Rosner Breakdown of academic impact, for papers by Bin Qiu Breakdown of academic impact, for papers by Simone Gusmini Breakdown of academic impact, for papers by É. Boucher Breakdown of academic impact, for papers by Ali Al Asadi Breakdown of academic impact, for papers by Samuel Le Sourd Breakdown of academic impact, for papers by Carla Rash Breakdown of academic impact, for papers by Giulia Riva
Rankless by CCL
2026